Related Experiment Video
Updated: Nov 10, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
The Diversity of the Intestinal Flora Disturbed After Feeding Intolerance Recovery in Preterm Twins
Ying Li1,2,3, Chunhong Jia2,3, Xiaojun Lin2
1Department of Neonatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Insights
Feeding intolerance in premature infants alters gut bacteria diversity and composition even after recovery. This condition may disrupt the natural development of the infant intestinal bacterial community.
Area of Science:
- Neonatal microbiome research
- Gastrointestinal health in premature infants
Background:
- Feeding intolerance (FI) is a common complication in premature infants, linked to poor growth and necrotizing enterocolitis.
- The gut microbiome's role in FI is established, but its long-term impact post-recovery remains unclear.
Purpose of the Study:
- To investigate the gut microbiome's diversity and composition in premature infants following feeding intolerance recovery.
- To compare the intestinal flora between infants with a history of feeding intolerance and those with normal feeding tolerance.
Main Methods:
- 16S rRNA gene sequencing of fecal samples from 11 pairs of premature twins/triplets.
- Longitudinal sample collection from admission up to 7 weeks or discharge.
- Analysis of microbial beta-diversity, predominant phyla, specific bacterial taxa, and KEGG pathways.
Main Results:
- No significant difference in overall beta-diversity between FI and feeding tolerance (FT) groups post-recovery.
- Significant differences in predominant phyla: Proteobacteria in FI group, Firmicutes in FT group.
- Distinct bacterial taxa and KEGG pathways (e.g., metabolism, DNA repair) differed significantly between groups post-recovery.
Conclusions:
- Significant differences in intestinal flora diversity persist after feeding intolerance recovery in premature infants.
- Feeding intolerance appears to disrupt the normal successional patterns of the infant gut bacterial community.
Abstract:
Background: Feeding intolerance (FI) is a common condition in premature infants that results in growth retardation and even necrotizing enterocolitis. The gut microbiome is linked to FI occurrence; however, the outcome after FI recovery is unclear. Methods: Fecal samples were collected from 11 pairs of premature twins/triplets for 16S rRNA gene sequencing. Initial fecal samples were collected shortly after admission, and then every other week until 7 weeks or discharge. Results: After FI recovery, there was no significant difference in the β-diversity of the intestinal flora between the FI group and the feeding tolerance (FT) group. By contrast, there was a significant difference in the β-diversity. Proteobacteria was the predominant phylum in the microbiome of the FI group, whereas Firmicutes was the predominant phylum in the microbiome of the FT group. The predominant bacteria with LDA >4 between the two groups at 13-15 days after birth, 19-28 days after birth, and at discharge were different, with the proportions of Bacillus, Clostridium butyricum, and Clostridium being highest in the FT group and Firmicutes, unidentified_Clostridiales, and Proteobacteria being highest in the FI group. Similarly, there were significant differences in the relative abundances of KEGG pathways, such as fatty acid metabolism, DNA repair and recombination proteins, energy metabolism, and amino acid metabolism, between the two groups (P < 0.01). Conclusions: There was a significant difference in diversity of the intestinal flora after feeding intolerance recovery. Feeding intolerance may disturb the succession of the intestinal bacterial community.
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

